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ABSTRACT: Successful matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging (MSI) relies on the se-
lection of the most appropriate matrix and optimization of the matrix application parameters. In order to achieve reproducible high 
spatial-resolution imaging data, several commercially available automated matrix application platforms have become available. 
However, the high cost of these commercial matrix sprayers is restricting access into this emerging research field. Here, we report 
an automated platform for matrix deposition, employing a converted commercially-available 3D printer ($300) and other parts 
commonly found in an analytical chemistry lab alow-cost alternative to commercial sprayers. Using printed fluorescent rhodamine 
B microarrays and employing experimental design, the matrix deposition parameters were optimized to minimize surface analyte 
diffusion. Finally, the optimized matrix application method was applied to image 3-dimensional MCF-7 cell culture spheroid sec-
tions (ca. 500 µm diameter tissue samples) and sections of mouse brain. Using this system, we demonstrate robust and reproducible 
observations of endogenous metabolite and steroid distributions with a high spatial resolution.
Introduction  
Over the last decade, MALDI mass spectrometry imaging 
(MSI) has become established as a powerful technique for 
observing the spatial distribution of small molecules,
1
 lipids,
2
 
peptides
3
 and proteins
4
 from the surface of a wide variety of 
samples. Using this technique, a spatial resolution of below 10 
µm has been demonstrated.
5–8
 However, in order to achieve 
such robust high spatial resolution data, reproducible sample 
preparation is crucial. Each stage in the preparation workflow 
must be carefully optimized for the specific tissue or sample to 
maintain the true spatial distributions of the biomolecules and 
reduce inter-sample variability.
9,10
 During matrix application, 
analyte diffusion is a major concern, and the selection of the 
most appropriate matrix and optimization of its application 
parameters is key to obtaining high quality and biologically 
relevant spectra directly from tissue samples.
11
 Subtle changes 
in application rate, drying times, matrix composition and area 
density all affect the ionization efficiency, the propensity to 
detect low abundance compounds and the reproducibility of 
the results obtained.
9
 The matrix crystal dimensions produced 
also affect the lateral resolution of the image, thus optimiza-
tion of matrix application can produce a crystal size smaller 
than the diameter of the laser, making the laser beam the limit-
ing factor in the imaging resolution that can be achieved.
9,11
  
Matrix can be applied with or without the addition of sol-
vents. Solvent-free application can reduce analyte delocaliza-
tion, whilst solvents can increase the number of peaks ob-
served, producing complementary biological information.
12
 
Solvent-based matrices can be applied either manually or us-
ing an automated robotic system, discretely as spots or contin-
uously as a coating.
11,13
 During manual matrix application, the 
homogeneity of the matrix coverage and the crystal size often 
varies depending on the operator whilst automated methods 
have been developed with the goal of removing inter-user 
variation.
14
 Automated sprayers remove the variability by con-
trolling the temperature, solvent flow rate, spray velocity and 
the number of passes; however, they are typically slower than 
the manual methods.
12
 A number of automated systems are 
commercially available, including the Bruker ImagePrep 
(Bremen, Germany), the SunChrom SunCollect (Frie-
drichsdorf, Germany) and the HTX-TM-Sprayer (HTX Tech-
nologies, LLC, NC, USA), however the cost of this equipment 
limits many research facilities’ accessibility to the technique.
15
 
Several less expensive automated matrix application strategies 
have been developed in academic research laboratories. These 
include, an automated acoustic spotter,
13
 the repurposing of an 
inkjet printer,
16
 and the use of an pneumatic sprayer on top of 
a pneumatically moveable base.
15
 These alternative printing 
nozzles apply different technologies to emit a spray of matrix 
capable of producing small uniform crystals suitable for MSI. 
Continuous inkjet (CIJ) printing is a low-cost method that 
pumps fluid through a nozzle to eject a continuous stream of 
uniform droplets at high frequency.
17
 The vibrations of a pie-
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 zoelectric actuator determines the size of the droplets, generat-
ing droplets  around 40 µm in diameter, producing low resolu-
tion printing.
17
 To reduce the droplet size produced and in-
crease the resolution, a number of drop-on-demand (DOD) 
printers have become commercially available, utilizing piezoe-
lectric printing.
18
 This involves applying a voltage to alter the 
pulse duration and the diameter of the nozzle which then con-
trols the size of the droplets.
17
 A disadvantage of this method 
is the high cost of the printer equipment required, as well as 
inkjet printers being prone to blockage of the nozzle. Alterna-
tively, in the absence of a current, a pneumatic nebulizer 
works using induction to atomize the liquid using a gas stream 
and produces droplets of down to 0.1 µm.
19
 This method re-
quires a lower flow rate than the inkjet options, thus using less 
liquid.
20
  
In this paper, we report an automated method for matrix depo-
sition, employing a converted commercial 3D printer ($300) 
and other parts commonly found in an analytical chemistry 
lab. Using printed rhodamine B microarrays and fluorescence 
imaging, we quantitate the extent of diffusion during matrix 
application. Through the use of experimental design, key ex-
perimental parameters, including temperature, gas pressure 
and nozzle height were varied and the effect on analyte diffu-
sion established. The optimization can be readily adapted for a 
range of similar devices. After optimization, matrix deposition 
using this system effectively reduced analyte diffusion. To 
demonstrate the use of this equipment, the optimized matrix 
application method was applied to observe metabolite distribu-
tions in MCF-7 spheroid sections (ca. 500 µm diameter tissue 
samples) with a consistently high spatial resolution. The re-
producibility and efficacy of the matrix application platform 
across larger samples was shown using mouse brain tissue 
sections (ca. 20 mm diameter) and with alternative matrices. 
 
Experimental 
Adaptation of a commercial 3D printer to a MALDI ma-
trix application platform and optimization of matrix appli-
cation conditions. An i3 duplicator 3D printer (WANHAO, 
Zhejiang, China) with a temperature controlled build plate (0-
120 
o
C) was used in this work. Adaptation of the printer takes 
half an hour, with all equipment costing a total of ca. $2600. 
See supplementary information for step-by-step instructions. 
Matrix deposition was achieved by replacing the printing ex-
truder with a commercially available electrospray emitter for 
nebulization (Bruker Daltonics, Bremen, Germany).  While 
comparatively expensive, a commercially available nebulizer 
was chosen as it is a robust device whose results can be repli-
cated in other laboratories; and it will be commonly available 
in mass spectrometry laboratories.  In these experiments no 
electrospray voltage was applied to the nebulizer relative to 
the sample slide.  The x,y,z position and feed rate of the ex-
truder is controlled with G-code instructions; a numerical con-
trol programme developed by Massachusetts Institute of 
Technology. The x,y positions were determined to cover the 
area of a slide, whilst the z height was determined as a dis-
tance between the emitter and the bed height. The z height was 
calibrated to 0 when the nebulizer was 2 mm above the bed. 
To convert the 3D printer, the printer’s extruder was removed 
and replaced with the nebulizer (Bruker Daltonics, Bremen, 
Germany) mounted onto a spacer fabricated from poly lactic 
acid (PLA) plastic and produced by 3D printing (figure 1). 
The 3D printed spacer was designed using an online software 
and converted to a .STL file for printing (see supplementary 
information for details). 
 
Figure 1. The printer extruder was removed and replaced with 
a (A) 3D printed block that held the (B) nebulizer in place. 
First, the (C) 3D block was screwed onto the structure and (D) 
subsequently the nebulizer held in place with a screw. 
Nitrogen was used as the nebulizer gas and set manually with 
an inline regulator. The nebulizer was connected to a nitrogen 
supply (70 psi) and the inlet of the sprayer was connected to a 
Rheodyne C1-2006 6 port valve (Valco Instruments, Texas, 
USA) using 100 µm internal diameter fused silica tubing (sup-
plementary figure 1). The valve was equipped with a 5 mL 
sample loop, through which matrix could be injected and sub-
sequently sprayed onto the slide. A Shimadzu LC-10ad HPLC 
pump (Shimadzu, Milton Keynes, UK) was connected to the 6 
port valve at a flow rate of 0.1 mL/minute (figure 2). The ma-
trix solution and application solvent used was 70:30 (v/v) ace-
tonitrile: water. The mass of matrix deposited by the optimized 
method on the commercial TM-sprayer
TM 
(HTX Technologies, 
LLC, NC, USA) was 2 mg. Therefore, the feed rate of the 
spray head and the flow rate of the solvent were optimized to 
match this area density. The velocity was set within the G-
code as F1000, which resulted in a velocity of 1100 
mm/minute. The total time taken for 8 passes of a glass slide 
was 25 minutes. For consistent performance, regular wash 
cycles were done with solvent before and after use. 
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 Figure 2. Outline of the printer setup. (A) The 3D printer used was the WANHAO Duplicator i3. (B) The extruder and fans were 
removed to leave the extruder housing block and remaining wires were insulated and secured in place with electrical tape. (C) A 3D 
printed block and nebulizer were secured in place and connected to a gas line and a 6-port HPLC valve with a 5 mL loop and a 
waste line. (D) An HPLC pump was connected and a solution of 70:30 (v/v) acetonitrile: water and a flow rate of 0.1 mL/minute 
was used during matrix application. 
Generation and matrix coating and fluorescence imaging 
of rhodamine B microarrays. 45 spots containing 50 droplets 
of 350 pL 0.01% rhodamine B (w/v) in water (Sigma-Aldrich, 
Missouri, USA) were dispensed onto a SuperFrost
TM
 glass 
slide using a SciFLEXARRAYER S5 microarray printer (Sci-
enion AG, Berlin, Germany) equipped with a PDC 80 dis-
pense capillary (Piezo Systems, Massachusetts, USA) with a 
50 µm nozzle aperture. HPLC-grade water used as the 
SciFLEXARRAYER solvent and was degassed preceding 
printing by sonication (30 minutes). The fluorescence was 
measured using a BioAnalyzer 4F/4S (LaVision BioTec, Bie-
lefeld, Germany) fluorescence scanner at 70 ms exposure time 
using a Cy5 filter. The area of observed fluorescence was 
measured using the circle area selection tool on ImageJ before 
and after matrix application. The standard deviation across the 
45 spots was calculated before and after matrix application. 5 
mg/mL 9-aminoacridine (9AA) in 70:30 (v/v) acetonitrile: 
water was used as the matrix with the exact parameters out-
lined in the discussion. A flow rate of 0.1 mL/minute and noz-
zle velocity of 1100 mm/minute was used for both the printer 
and commercial TM-sprayer
TM
. 
Scanning electron microscopy. The matrix-coated rhodamine 
B slides were mounted on aluminium stubs with carbon tabs 
attached and sputter coated with 20 nm gold palladium (Em-
scope, Island Scientific, Ventnor, UK). The samples were 
viewed using a Hitachi S-4700 scanning electron microscope 
(Tokyo, Japan). 
Cell culture and spheroids preparation. MCF-7 cells were 
donated at passage 52 from the Queen’s Medical Research 
Institute (QMRI), Edinburgh (UK). Both monolayer cells and 
spheroids were grown in Dulbecco’s Modified Eagles Medium 
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 (DMEM) (Thermo-Fisher, Massachusetts, USA) supplement-
ed with 10% fetal calf serum (FCS) (Sigma Aldrich, Missouri, 
USA) and 1% penicillin (Thermo-Fisher, Massachusetts, 
USA). Monolayer cells were routinely seeded every 4 days in 
75 cm
3
 flasks with 1 mL cells and 9 mL fresh media. The me-
dia was replaced every 48 hours. 
Spheroids were obtained using the hanging drop method.
21
 
Approximately 6000 cells were seeded into 20 µL droplets 
that were then suspended from the lid of a petri dish. A reser-
voir of 10 mL media was placed in the bottom of the dish. 
Spheroids were fed with 5 µL fresh media every 48 hours. 
Spheroids were incubated at 36.5 °C, 5% CO2 and 95% hu-
midity for 8 days before imaging. 
MALDI imaging sample preparation 
Sample preparation of spheroids. 8 day old untreated MCF-
7 spheroids were prepared using the following method. Media 
was removed and spheroids were washed with ammonium 
formate (20 µL, 50 mM). Each spheroid was picked up and 
placed into a droplet from which maximal liquid was removed. 
Blue dyed gelatin (40 µL, 10% w/v) was placed onto the sphe-
roids and frozen on isopentane and dry ice (2 minutes). The 
gelatin blocks were then snap frozen in liquid nitrogen and 
stored (-80 °C) until sectioning. Sectioning was performed 
using a cryostat (-21 
o
C) (Leica CM 1900 (Leica Biosystems, 
Nussloch, Germany). Sections (15 µm) were cut and thaw 
mounted onto conductive indium tin-oxide (ITO)-coated glass 
slides (Bruker Daltonics, Bremen, Germany). Consecutive 
sections were taken for haematoxylin and eosin staining. 
Sample preparation of mouse brain: Licensed procedures 
were performed under the UK Animals (Scientific Procedures) 
Act, 1986. C57BL/6 mice (6–7 weeks, male) were from Har-
lan Olac Ltd. (Bicester, UK). Animals were killed by decapita-
tion at 09:00 h. Brain tissue was snap frozen in liquid nitrogen 
and stored (−80 °C) until MSI analysis. Tissue sectioning was 
adapted from Cobice et al.
22
 Briefly, sectioning was performed 
using a cryostat (Leica Microsystems Inc., Bannockburn, IL, 
USA) and gelatin solution (10% w/v) as embedding media. 
Sagittal brain sections (10 µm) were cut and thaw mounted 
onto conductive ITO-coated glass slides (Bruker Daltonics, 
Bremen, GmbH) pre-coated with GirT-reagent (0.15 mg/cm
2
). 
Tissue sections were stored in a vacuum desiccator (RT, 1h) 
and then at −80 °C until MSI analysis. 
Matrix application of MCF-7 spheroids. The matrix solution 
was 5 mg/mL of 9AA in 70:30 (v/v) acetonitrile: water. For 
the commercial sprayer, the TM-sprayer
TM 
(HTX Technolo-
gies, LLC, NC, USA) was used to apply 8 coats of matrix at a 
flow rate of 0.1 mL/minute at 80 °C with a gas pressure of 10 
psi and a velocity of 1100 mm/minute. Matrix area density 
was 0.11 mg/cm
2
. The optimized converted 3D printer was 
used to apply 8 coats of matrix at a flow rate of 0.1 mL/minute 
at 40 °C with a gas pressure of 50 psi and a z height of 30 mm. 
The velocity was set within the G-code as F1000, which re-
sulted in a velocity of 1100 mm/minute. Matrix area density 
was 0.11 mg/cm
2
. 
Matrix application of mouse brain: The matrix solution was 
10 mg/mL of α-cyano-4-hydroxycinnamic acid (CHCA) in 
60:40 (v/v) acetonitrile: water with 0.1% TFA. The velocity 
was set within the G-code as F800, which resulted in a veloci-
ty of 800 mm/minute. The total time taken for 4 passes of a 
glass slide was 20 minutes. For consistent performance, regu-
lar wash cycles were done with solvent before and after use. 
Matrix area density was 0.22 mg/cm
2
. 
Mass spectrometry imaging. A 12T SolariX FT-ICR MS 
(Bruker Daltonics, Bremen, Germany) equipped with a 
MALDI ionization source was operated in negative ionization 
mode to acquire spectra between 98-1500 m/z. The laser raster 
increment was set to 40 µm along both the x and y axis with a 
smart walk of 50 µm. Laser focus was set to minimum, with a 
frequency of 1000 Hz. Ions were accumulated across 300 laser 
shots for each mass analysis. For mouse brain analysis, source 
was operated in positive ionization mode to acquire spectra 
between 250-2500 m/z. The laser raster increment was set to 
75 µm along both the x and y axis with a smart walk of 50 µm. 
Laser focus was set to small, with a frequency of 1000 Hz. 
Ions were accumulated across 300 laser shots for each mass 
analysis. Calibration of the spheroid data was performed post-
processing using a pre-determined list of internal calibrants 
(supplementary information table 1). The images were then 
analyzed without normalization using FlexImaging 4.1 
(Bruker Daltonics, Bremen, Germany) and discriminatory 
analysis completed using SCiLS (Bruker Daltonics, Bremen, 
Germany). The metabolites were identified using the Human 
Metabolome Database (HMDB) using an error tolerance of 10 
ppm for [M-H]
-
. (http://www.hmdb.ca/spectra/ms/search). 
H&E Staining. Sectioned spheroids were placed onto a glass 
slide and stored in a vacuum desiccator (RT, 18h) Cells were 
first washed with water. Sections were covered with haema-
toxylin (Sigma-Aldrich, Missouri, USA) (3 minutes) and 
washed with running water. The slide was coated with tap 
water (1 minute), then acid alcohol (Sigma-Aldrich, Missouri, 
USA) (20 seconds) and then washed using water. Eosin (Sig-
ma-Aldrich, Missouri, USA) was added (1 minute) and then 
washed with water. The stained cells were then air dried be-
fore being imaged under the 40X objective on an inverted 
AE2000 (Motic, Hong Kong) microscope.   
Results and Discussion 
Optimization of MALDI matrix application using rhoda-
mine B microarrays. Delocalization during matrix applica-
tion was measured using microarrays of rhodamine B spots 
(0.01 % w/v) printed on glass slides. Rhodamine B is a water-
soluble fluorescent dye which provided a model of low mo-
lecular weight metabolites that commonly delocalize in 
MALDI MSI. 45 individual spots per slide provided a high 
number of technical repeats to produce statistically robust data 
for assessing the extent of delocalization. Each slide was coat-
ed with a MALDI matrix (9AA) using the 3D-printer platform 
and the average change in area was calculated. To identify the 
optimal matrix application conditions for minimizing delocali-
zation, a user defined experimental design was compiled using 
Design Expert 10 (Stat-Ease, Minneapolis, USA) with discrete 
increments of 10 for 3 matrix application variables: nebulizing 
gas pressure (40-60 psi), build-plate temperature (20-40 °C) 
and nebulizer z height (i.e. height of nebulizer above the sam-
ple surface) (10-30 mm). No voltage was applied as the nebu-
lizer was used for nebulization. This process produced a set of 
27 discrete conditions for matrix application. A slide of 45 
replicate rhodamine B spots was coated using each of the 27 
defined conditions. The change in area of fluorescence before 
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 and after matrix application was recorded using a BioAnalyzer 
4F/4S (LaVision BioTec, Bielefeld, Germany) fluorescence 
scanner and measured using ImageJ, In order to quantitate 
analyte diffusion as a consequence of matrix application, the 
average area change in fluorescence area after matrix coating 
was calculated (figure 3 and supplementary information table 
2).  
 Figure 3. A bubble plot showing how the 27 matrix applica-
tion conditions affect the change in area of rhodamine B fluo-
rescence. The size of the circle is the percentage change in 
area of fluorescence after matrix application (diffusion) and 
the dark to pale blue color scale represents increasing gas 
pressure.  
By comparing the data collected over all the conditions tested, 
it can be seen that increasing both the z height and temperature 
reduced the extent of rhodamine B delocalization (supplemen-
tary figure 2). In contrast, varying the gas pressure had a lesser 
effect on the delocalization. The optimized parameters of 40 
°C build-plate temperature, 30 mm nebulizer z height and 50 
psi gas pressure produced a dry matrix application with a 9.44 
% change in fluorescence area after matrix application. In 
contrast, the worst conditions were identified as 20 °C, 10 mm 
z height and 60 psi gas pressure, producing a 403 % increase 
in area of rhodamine B with visible smearing of the rhodamine 
B spots after matrix application (figure 4).  
 
Figure 4. Rhodamine B spots (0.01 % w/v, 17.5 µL) were 
spotted using a microarray printer, and the fluorescence im-
aged at 70 ms exposure. The change in area was measured for 
all 27 conditions tested. Here the images of the optimized (A, 
40 
°
C, 30 mm, 50 psi) and worst (B, 20 
°
C, 10 mm, 60 psi) 
conditions before and after matrix application are shown. 
Scale bar 1 mm.  
Imaging the MALDI matrix crystal size using scanning 
electron microscopy. The crystal size produced during matrix 
application defines the spatial resolution and the extent of 
analyte diffusion.
11
 By reducing the crystal size, a greater spa-
tial resolution is achieved.
9
 To assess the size of the matrix 
crystals, scanning electron microscopy (SEM) was used. Crys-
tal size on the rhodamine printed slides was determined for 
both the optimized and worst parameters for the modified 3D 
printer platform, as well as for our laboratory’s standard appli-
cation protocol using a commercially available system (the 
HTX TM-sprayer) (figure 5). SEM images revealed that the 
worst conditions produced a coverage of large heterogeneous 
crystals. In contrast, the optimized conditions produced a ho-
mogenous coating of small regularly-sized crystals across the 
sample which were comparable to that of the commercial 
printer.  
 
Figure 5. Scanning electron microscope images of the crystals 
produced under the (A) worst 3D printer conditions (B) opti-
mized 3D printer conditions and (C) optimized commercial 
HTX TM-sprayer conditions. The worst conditions produced 
large inhomogeneous crystals whilst the optimized method 
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 produced small crystals with a uniform coverage that were 
similar to those observed using the commercial sprayer.  
MALDI imaging of metabolites in tissue. Multicellular tu-
mor spheroids (MTS) are spherical self-assembled cell cul-
tures that grow up to 1 mm in diameter and are the most com-
monly used 3D model for assessing drug penetration and effi-
cacy ex vivo.
23,24
 MTS are known to have a diffusion limit of 
150 - 200 µm to molecules including oxygen, glucose and 
other metabolites, above which the inefficient mass transport 
causes metabolic waste accumulation and gradients of nutri-
ents and waste products.
25,26
 A number of groups have used 
MSI to observe the distribution of proteins
27
 and drugs
28
 with-
in spheroids. However due to their small size any delocaliza-
tion caused by matrix application can greatly affect the biolog-
ical validity of the results obtained. Based on the optimal con-
ditions obtained through experimental design, MCF-7 sphe-
roids were sectioned and subsequently imaged using MALDI 
FT-ICR MS at 40 µm imaging resolution. These sub-1 mm 
tissues provide an effective model to understand the spatial 
distribution of molecules in small systems. The resulting MSI 
data achieved using the optimized and non-optimal 3D printer 
matrix application conditions were compared to the current 
laboratory standard protocol using a HTX-TM sprayer. Figure 
6 shows the distribution of a number of metabolites including 
glutathione, adenosine triphosphate (ATP) and adenosine 
monophosphate (AMP) throughout the spheroid beside an 
optical image of an adjoining H&E stained section to validate 
the spheroid morphology after cryosectioning. Without opti-
mization, the home-built matrix sprayer produced extensive 
diffusion of molecules including glutathione. This resulted in 
the analytes diffusing out of the tissue and into the embedding 
medium, producing a biologically inaccurate distribution. The 
nebulizer was located near the sample at a high gas pressure 
without a heated bed. Under these lower temperature condi-
tions, crystals form more slowly and therefore produce larger 
heterogeneous distributions, incorporating analytes across 
larger regions with a poor signal-to-noise ratio for the analytes 
observed.
9 
However, through optimization of the home-built 
matrix sprayer, including increasing the z height of the nebu-
lizer and increasing the temperature of the heated bed, the 
distributions resembled those observed under the optimized 
conditions of a commercially available sprayer, with a number 
of analytes having an improved signal from that observed us-
ing the commercial sprayer. Glutathione was observed to en-
tirely delocalize outside of the spheroid prior to the home-built 
matrix sprayer optimization, however under the optimized 
conditions it localized towards the centre of the spheroid, simi-
larly to that observed using the commercially available spray-
er. A similar distribution was observed for the oxidized form 
of glutathione. In contrast, ATP distributed to the outer region 
of the spheroid under all spraying conditions. The most no-
ticeable difference as a result of the optimization is the distri-
bution of AMP. After optimization, AMP appears uniformly 
distributed, suggesting that the localization to the outer part of 
the spheroid that is observed using non-optimized matrix dep-
osition is an artefact caused by analyte delocalization. Im-
portantly, these distributions were reproducibly observed us-
ing both the commercially available sprayer and the 3D printer 
(supplementary figure 3).
 
Figure 6. MCF-7 spheroids were imaged at 40 µm lateral laser resolution using the FT-ICR MS. Distributions of molecules were 
observed and compared between the non-optimized and optimized parameters of the 3D printer compared to that of the current pro-
tocol using a commercially available sprayer. The H&E sections are shown to confirm the morphology of the cryosectioned sphe-
roids. 
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 To further demonstrate the reproducibility and efficacy of the 
matrix coater over a larger area and with alternative matrices, 
the 3D printer was used to coat sections of mouse brain with 
CHCA. The sample was imaged at 75 µm lateral laser resolu-
tion using FT-ICR MS (figure 7). The spatial distributions of 
two endogenous steroids, derivatized with Girard’s reagent T 
(as described previously (22)) were determined (figure 7B and 
Fig 7C). The observed distributions closely matched previous-
ly reported results.
22
 Importantly, the spatial distribution of the 
data was consistent throughout the ~20 mm tissue section, 
with clear partitioning of the endogenous steroids throughout 
the tissue. These observations confirm the consistency of ma-
trix deposition using our matrix application platform.  
 
Figure 7. The 3D printer was used to coat sections of mouse brain with CHCA as the matrix.  The spatial distributions of two en-
dogenous steroids were observed and found to closely match previously reported results.
22
 Tissue was imaged at 75 µm lateral laser 
resolution using the FT-ICR MS. (A) optical image of sagittal cryosection of murine brain, (B) MSI heat map of Corticosterone 
derivative (GirT-CORT) at m/z 460.3171 ± 0.002 Da, (C) 11-dehydrocorticosterone (GirT-11DHC) at m/z 458.2998 ± 0.002 Da 
and (D) MSI images superimposition of corresponding steroids derivatives. Signal intensity is depicted by colour on the scale 
shown. Scale bar (5 mm).  
Conclusion 
Here we have shown that a 3D printer can be converted into an 
effective automated MALDI matrix applicator which operates 
with minimal analyte diffusion during matrix application. Us-
ing fluorescent microarrays and experimental design the con-
ditions for 9AA matrix application were optimized. With a 
heated bed and an increased z height of the sprayer, it was 
possible to minimize sample wetting and therefore reduce 
analyte diffusion. These optimized conditions could then be 
used to reproducibly image MCF-7 spheroids and identify 
numerous metabolites with reduced analyte delocalization. 
This produced images with comparable distributions to those 
observed using a commercially available printer at a fraction 
of the set-up cost compared to commercially available sys-
tems. The efficacy of the device was further demonstrated 
over larger areas and with alternative matrices by imaging a 
mouse brain coated with CHCA. As a result, initial findings 
shown here demonstrate the potential application of this sys-
tem for effective MALDI matrix application to biological tis-
sue sections, thus enabling reliable low-cost high-resolution 
MSI. 
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